Funds · compare two funds
Are these two funds really different?
Pick two funds to see how much of their Indian equity is the same: the companies both hold, and what each holds that the other does not.
Data periodFund holdingsEach fund’s latest monthly disclosureNSE prices23 Oct 2026Data status →
HDFC Pharma and Healthcare Fund vs Mirae Asset Nifty 500 Healthcare ETF
Overlap adds up, for every company both funds hold, the smaller of its two shares of each fund’s disclosed Indian equity: identical portfolios overlap 100%, funds with nothing in common 0%. A figure describes how alike the portfolios are; it is not a judgement of either fund. Method →
See both funds combined in the Portfolio X-ray →
Top shared holdings
25 companies both funds hold · largest common part first
Only in A
13 companies · largest first
- Shilpa Medicare Limited3.34%
- Molbio Diagnostics Limited2.08%
- Jupiter Life Line Hospitals Limited1.74%
- Metropolis Healthcare Limited1.73%
- Symbiotec Pharmalab Limited1.41%
- Thyrocare Technologies Limited1.13%
- CORONA Remedies Limited1.07%
- Entero Healthcare Solutions Limited1.04%
- Jubilant Pharmova Limited0.96%
- Eris Lifesciences Limited0.95%
- Novartis India Limited0.57%
- Bajaj Healthcare Limited0.55%
- Laxmi Dental Limited0.36%
Only in B
19 companies · largest first
- Laurus Labs Limited5.72%
- Aurobindo Pharma Limited3.43%
- Fortis Healthcare Limited2.98%
- Mankind Pharma Limited2.10%
- Ajanta Pharma Limited1.22%
- Dr. Lal Path Labs Ltd.1.15%
- Abbott India Limited1.04%
- Piramal Pharma Limited0.95%
- Granules India Limited0.93%
- Narayana Hrudayalaya Ltd.0.92%
- Onesource Specialty Pharma Limited0.89%
- GlaxoSmithKline Pharmaceuticals Limited0.85%
- Emcure Pharmaceuticals Limited0.60%
- Natco Pharma Limited0.55%
- Syngene International Limited0.51%
And 4 more.
Sector mix side by side
Share of each fund’s disclosed equity
| Sector | A | B | Difference |
|---|---|---|---|
| Healthcare | 91.2% | 100.0% | -8.82 pp |
| Consumer Services | 1.0% | 0.0% | +1.04 pp |
| Not classified | 7.8% | 0.0% | +7.78 pp |
Built from each fund’s latest monthly disclosure of Indian listed shares, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not part of the comparison. Not a recommendation. Method →